|
1
|
Leduc D, Senikas V, Lalonde AB, et al:
Active management of the third stage of labour: prevention and
treatment of postpartum hemorrhage. J Obstet Gynaecol Can.
31:980–993. 2009.PubMed/NCBI
|
|
2
|
World Health Organization. WHO
recommendations for the prevention of postpartum haemorrhage. World
Health Organisation: Department of Making Pregnancy Safer; Geneva,
Switzerland: 2007
|
|
3
|
Carroli G, Cuesta C, Abalos E and
Gulmezoglu AM: Epidemiology of postpartum haemorrhage: a systematic
review. Best Pract Res Clin Obstet Gynaecol. 22:999–1012. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wedisinghe L, Macleod M and Murphy DJ: Use
of oxytocin to prevent haemorrhage at caesarean section - a survey
of practice in the United Kingdom. Eur J Obstet Gynecol Reprod
Biol. 137:27–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su Y, Xu Z and Jiang S: Practical
Obstetrics. 2nd edition. Shandong Science and Technology Press;
Jinan, Shandong, China: pp. 4862004
|
|
6
|
Begley CM, Gyte GM, Devane D, McGuire W
and Weeks A: Active versus expectant management for women in the
third stage of labour. Cochrane Database Syst Rev.
11:CD0074122011.
|
|
7
|
Gizzo S, Patrelli TS, Gangi SD, et al:
Which uterotonic is better to prevent the postpartum hemorrhage?
Latest news in terms of clinical efficacy, side effects, and
contraindications: a systematic review. Reprod Sci. 20:1011–1019.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roach MK, Abramovici A and Tita AT: Dose
and duration of oxytocin to prevent postpartum hemorrhage: a
review. Am J Perinatol. Dec 3–2012.(Epub ahead of print).
|
|
9
|
Oladapo OT, Akinola OI, Fawole AO, et al:
Active management of third stage of labor: evidence versus
practice. Acta Obstet Gynecol Scand. 88:1252–1260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rath W: Prevention of postpartum
haemorrhage with the oxytocin analogue carbetocin. Eur J Obstet
Gynecol Reprod Biol. 147:15–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Higgins L, Mechery J and Tomlinson AJ:
Does carbetocin for prevention of postpartum haemorrhage at
caesarean section provide clinical or financial benefit compared
with oxytocin? J Obstet Gynaecol. 31:732–739. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Bonis M, Torricelli M, Leoni L, et al:
Carbetocin versus oxytocin after caesarean section: similar
efficacy but reduced pain perception in women with high risk of
postpartum haemorrhage. J Matern Fetal Neonatal Med. 25:732–735.
2012.PubMed/NCBI
|
|
13
|
Gibbins KJ, Albright CM and Rouse DJ:
Postpartum hemorrhage in the developed world: whither misoprostol?
Am J Obstet Gynecol. 208:181–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cordovani D, Balki M, Farine D, et al:
Carbetocin at elective Cesarean delivery: a randomized controlled
trial to determine the effective dose. Can J Anaesth. 59:751–757.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Su LL, Chong YS and Samuel M: Carbetocin
for preventing postpartum haemorrhage. Cochrane Database Syst Rev.
4:CD0054572012.
|
|
16
|
Vaid A, Dadhwal V, Mittal S, et al: A
randomized controlled trial of prophylactic sublingual misoprostol
versus intramuscular methyl-ergometrine versus intramuscular
15-methyl PGF2alpha in active management of third stage of labor.
Arch Gynecol Obstet. 280:893–897. 2009. View Article : Google Scholar
|
|
17
|
Lamont RF, Morgan DJ, Logue M and Gordon
H: A prospective randomised trial to compare the efficacy and
safety of hemabate and syntometrine for the prevention of primary
postpartum haemorrhage. Prostaglandins Other Lipid Mediat.
66:203–210. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buttino L Jr and Garite TJ: The use of 15
methyl F2 alpha prostaglandin (Prostin 15M) for the control of
postpartum hemorrhage. Am J Perinatol. 3:241–243. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abdel-Aleem H, Abol-Oyoun EM, Moustafa SA,
et al: Carboprost trometamol in the management of the third stage
of labor. Int J Gynaecol Obstet. 42:247–250. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oleen MA and Mariano JP: Controlling
refractory atonic postpartum hemorrhage with Hemabate sterile
solution. Am J Obstet Gynecol. 162:205–208. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ezeh UO and Pearson M: The control of
blood loss at cesarean section with intramyometrial prostaglandin
F2 alpha analog versus intravenous synthetic oxytocin. Am J Obstet
Gynecol. 173:353–354. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nordström L, Fogelstam K, Fridman G,
Larsson A and Rydhstroem H: Routine oxytocin in the third stage of
labor: a placebo controlled randomized trial. Br J Obstet Gynecol.
104:781–786. 1997.PubMed/NCBI
|
|
23
|
Güngördük K, Asicioglu O, Celikkol O,
Olgac Y and Ark C: Use of additional oxytocin to reduce blood loss
at elective caesarean section: A randomised control trial. Aust N Z
J Obstet Gynaecol. 50:36–39. 2010.PubMed/NCBI
|
|
24
|
Carboprost [Package insert]. Kirkland.
Quebec, Canada: Pfizer; 2004
|
